Lipitor Information
What's inside Lipitor
Lipitor Active Ingredients: atorvastatin, details.| Lipitor Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Lipitor 10 mg | tablet | oral | 1.0 each | OTC |
| Lipitor 20 mg | tablet | oral | 1.0 each | OTC |
| Lipitor 40 mg | tablet | oral | 1.0 each | OTC |
| Lipitor 80 mg | tablet | oral | 1.0 each | OTC |
Recent Lipitor Side Effects
Posted by hasina 1 day ago
Hi ,did you ever heard of blood type diet ?every blood group has different chemistry and different way of metabolism.there is...
Posted by fgwilder 4 days ago
About eight years ago I felt heaviness in my chest along with some pain/discomfort when doing hard physical labor and occasio...
Posted by oldcarpetcleaner 4 days ago
THE P.ORANGI REPORT
VERY VERY VERY ANGRY.
THE FOLLOWING IS AN abbreviated EXTRACT FROM MED SAFE NEW ZEALAND.
A watching br...
Lipitor in the News
Pfizer: Outsourcing is necessary business - Therapeutics Daily (subscription) (press release)
Basically, he?s saying, get used to it. Pfizer is preparing for the loss of its patent protection on the world?s top-selling drug, Lipitor. The ...
Sun Mar 09 13:28:34 -0400 2008
Pfizer outlines plans to face life after Lipitor to analysts - Pharma Times (subscription)
... are still unsure whther the firm has the means to deal with the patent loss it will face on the cholesterol blockbuster Lipitor (atorvastatin) in 2010. ...
Thu Mar 06 05:52:35 -0500 2008
Pfizer steels itself for Lipitor expiry - Financial Times
... structure would prepare it for the impending expiry of the patent for its blockbuster cholesterol drug Lipitor, worth some $12bn in annual sales. ...
Wed Mar 05 20:53:59 -0500 2008
Lipitor Chemical Information
atorvastatin - The calcium salt form of atorvastatin, a synthetic lipid-lowering agent. Atorvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. Atorvastatin also increases the number of LDL receptors on hepatic cell surfaces to enhance uptake and catabolism of LDL and reduces LDL production and the number of LDL particles. This agent lowers plasma cholesterol and lipoprotein levels and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04)
Lipitor RSS Feed